Soleus Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98K Buy
+20,000
New +$117K ﹤0.01% 96
2023
Q2
– Sell
-80,000
Closed -$1.33M – 107
2023
Q1
$1.33M Buy
+80,000
New +$1.13M 0.14% 69

Other funds holding RXST

Soleus Capital Management's RXST Position: Q3 2026 in Review

Soleus Capital Management opened a new position in RxSight (RXST) in Q3 2026: 20,000 shares worth $98K. The stake represents ﹤0.01% of the portfolio and ranks #96 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in RXST as recently as Q1 2023.

Soleus Capital Management first reported a position in RXST in Q1 2023 and has held it in 2 quarters since. The position peaked at $1.33M in Q1 2023. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Soleus Capital Management held 20,000 shares of RxSight worth $98K as of Q3 2026.
  • RxSight was a new Soleus Capital Management position in Q3 2026.
  • RxSight made up ﹤0.01% of Soleus Capital Management's portfolio in Q3 2026, its #96 holding.
  • Soleus Capital Management first reported a position in RxSight in Q1 2023 and has held it in 2 quarters since.
  • Soleus Capital Management's RxSight position peaked at $1.33M in Q1 2023.
  • 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.